Envestnet Asset Management Inc. Boosts Position in Haleon PLC Sponsored ADR $HLN

Envestnet Asset Management Inc. boosted its position in shares of Haleon PLC Sponsored ADR (NYSE:HLN) by 6.5% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 7,857,196 shares of the company’s stock after acquiring an additional 476,823 shares during the quarter. Envestnet Asset Management Inc.’s holdings in Haleon were worth $81,479,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of HLN. Hanson & Doremus Investment Management increased its position in Haleon by 234.1% during the second quarter. Hanson & Doremus Investment Management now owns 2,372 shares of the company’s stock valued at $25,000 after acquiring an additional 1,662 shares during the last quarter. Banque Transatlantique SA purchased a new stake in Haleon in the first quarter worth about $27,000. Ransom Advisory Ltd purchased a new stake in Haleon in the first quarter worth about $31,000. Deutsche Bank AG increased its position in Haleon by 267.8% in the first quarter. Deutsche Bank AG now owns 3,126 shares of the company’s stock worth $32,000 after buying an additional 2,276 shares in the last quarter. Finally, Hilltop National Bank purchased a new stake in Haleon in the second quarter worth about $33,000. Hedge funds and other institutional investors own 6.67% of the company’s stock.

Haleon Stock Performance

NYSE:HLN opened at $9.04 on Thursday. The company has a current ratio of 0.87, a quick ratio of 0.63 and a debt-to-equity ratio of 0.48. Haleon PLC Sponsored ADR has a 12-month low of $8.71 and a 12-month high of $11.42. The stock has a 50-day moving average price of $9.34 and a 200 day moving average price of $9.97. The stock has a market capitalization of $40.23 billion, a P/E ratio of 23.17, a P/E/G ratio of 2.66 and a beta of 0.20.

Haleon Increases Dividend

The firm also recently announced a semi-annual dividend, which was paid on Thursday, September 18th. Investors of record on Friday, August 15th were given a dividend of $0.0555 per share. This is an increase from Haleon’s previous semi-annual dividend of $0.05. This represents a dividend yield of 190.0%. The ex-dividend date was Friday, August 15th. Haleon’s dividend payout ratio (DPR) is 28.21%.

Analysts Set New Price Targets

HLN has been the subject of a number of analyst reports. Wall Street Zen cut Haleon from a “buy” rating to a “hold” rating in a research report on Saturday, July 12th. Weiss Ratings restated a “hold (c)” rating on shares of Haleon in a research report on Wednesday, October 8th. Barclays cut Haleon from an “overweight” rating to an “equal weight” rating in a research report on Tuesday, September 16th. Finally, The Goldman Sachs Group upgraded Haleon from a “neutral” rating to a “buy” rating in a research report on Wednesday, September 10th. One analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $12.33.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.